Discover who we are, what drives us, and how we’re transforming care — with purpose, science, and heart.
They guide us in building trust, improving lives, and ensuring that innovation always serves humanity.
We constantly develop medical solutions that prioritize patient well-being, comfort, and autonomy, utilizing the most advanced technology and a deep understanding of their needs.
We maintain an unwavering commitment to high-quality medical research, scientific evidence, and the continuous development of more effective and personalized treatments.
We recognize that behind every diagnosis is a person with unique needs, so we approach each solution with compassion, respect, and a deep understanding of the challenges our patients face.
We work to democratize access to high-quality healthcare solutions by designing products and services that are economically viable and adaptable to different socioeconomic and cultural contexts.
We maintain the highest ethical standards in all our operations, from research and development to marketing and customer service, ensuring the integrity and trust of all our stakeholders.
We are committed to a business model that not only cares for people's health, but also for the environment and the communities in which we operate, promoting responsible practices and a positive social impact.
We foster a culture of constant learning and adaptation, where every challenge is an opportunity to grow, innovate, and offer increasingly effective and patient-centered solutions.
Receiving a diagnosis of diabetes or a cardiometabolic condition isn’t just about numbers, tests, or treatments. It brings fear, uncertainty, and unanswered questions. How will my life change? Will I be able to do what I used to? Will I have to face this alone?
At Qardiabetes, we understand that this moment of uncertainty isn’t only clinical — it’s deeply human. That’s why we exist: to be there when the heart needs more than technology — it needs empathy, clarity, and trust. We believe that health is cared for with science, yes, but also with listening, with presence, and with a genuine commitment. From the very first appointment to each day at home, we walk with you.
We are a company built on the purpose of caring for life. Through reliable, innovative, and accessible medical solutions, we want every person to feel that they are not alone. We’re here to support, inform, and make the path to a full life easier. Because more than products, we offer a promise: to care for your heart, from our heart.
“From heart to heart” is more than just a phrase. It’s the way we work, decide, and serve every day at Qardiabetes. It’s our approach to health as a human connection before a technical process.
From the research and design of each product to patient care and long-term support, everything we do comes from a genuine commitment to improve lives. We work with heart — to care for yours.”
Diabetes is one of the most pressing global health challenges of our time. As of 2024, over 589 million adults worldwide live with diabetes — a figure projected to reach 853 million by 2050. The disease caused 3.4 million deaths in 2024, accounting for 9.3% of all global deaths, and placed a staggering USD 1.015 trillion burden on healthcare systems.
Even more concerning, 1 in 3 adults with diabetes remains undiagnosed, and 1 in 6 pregnancies is affected by high blood sugar. These statistics highlight the urgent need for global action, education, and innovation in diabetes care.
Million people worldwide have diabetes in 2024
Million – Projection 2050
1 in 3 undiagnosed
1 in 6 pregnancies affected
Million deaths annually
Trillion in healthcare spending
Source: IDF Diabetes Atlas, 11th Edition (2025), International Diabetes Federation.
In Latin America, approximately 4 in 10 adults are affected by cardiometabolic syndrome — a growing public health concern driven by rising rates of obesity, sedentary lifestyles, and poor nutrition. Hypertension affects over 35% of the adult population, while overweight and obesity are present in more than two-thirds of adults.
The burden of diabetes alone resulted in over 224,000 deaths in 2024, and healthcare spending related to diabetes reached nearly USD 81 billion, accounting for 8% of global diabetes-related expenses. Projections suggest that without effective interventions, the region will continue facing rising health costs, premature mortality, and deepening inequality.
Source: Pan American Health Organization (PAHO), International Diabetes Federation (IDF), 2025 Latin America Meta-Analysis
of adults affected by cardiometabolic syndrome in Latin America
diabetes-related deaths in Latin America and the Caribbean (2024)
Billions spent on diabetes care in the region (2024)
of adults are overweight or obese
prevalence of hypertension (ages 30–70)
Million adults with diabetes
undiagnosed
cost per person
+ deaths in 2024
In Colombia, more than 3 million adults are living with diabetes — a national prevalence of 8.3%. While progress has been made in diagnosis and awareness, approximately 16.2% of cases remain undiagnosed.
The economic impact is substantial: the average annual healthcare cost per person with diabetes is over USD 1,900, with national spending estimated at nearly USD 5.7 billion. In 2024, the country recorded over 15,000 diabetes-related deaths. These figures emphasize the importance of education, early detection, and equitable access to quality care across the country.
Source: IDF Diabetes Atlas, 11th Edition (2025), International Diabetes Federation.
Chief Mental Health Officer
Licensed Clinical Psychologist
Family & Relationship Counselor
